Shares of Medtronic PLC MDT rallied 2.27% to $89.94 Friday, on what proved to be an all-around poor trading session for the ...
Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...
Medtronic plc (NYSE:MDT – Get Free Report) shares were up 0.3% on Thursday after UBS Group raised their price target on the stock from $85.00 to $95.00. UBS Group currently has a neutral rating on the ...
Shares of Medtronic PLC MDT advanced 1.08% to $87.94 Thursday, on what proved to be an all-around rough trading session for ...
Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, ...
Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...
Truist raised the firm’s price target on Medtronic (MDT) to $93 from $89 and keeps a Hold rating on the shares after its Q3 earnings beat.
Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.
In an “urgent medical device correction,” the company urges clinicians to remind patients to monitor their glucose levels during takeoffs and landings.
Truist Financial analyst Richard Newitter maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $93.00.
Past week dominated by good news and a few corporate earnings (0:25). Taiwan Semiconductor and Intel and Broadcom (3:30).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback